NYSE:COV - Covidien Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0350 0.00 (0.00 %)
(As of 08/22/2018 03:37 AM ET)
Previous Close$0.0350
Today's Range$0.0350 - $0.0350
52-Week Range$65.97 - $108.57
VolumeN/A
Average Volume3.88 million shs
Market Capitalization$48.98 billion
P/E RatioN/A
Dividend Yield1.35%
Beta1.01
Covidien logoCovidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Receive COV News and Ratings via Email

Sign-up to receive the latest news and ratings for COV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNYSE:COV
CUSIPG2554F11
WebN/A
Phone+353-1-4381700

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins19.02%
Return on Equity20.06%
Return on Assets9.92%

Miscellaneous

EmployeesN/A
Outstanding Shares454,510,000
Market Cap$48.98 billion

Covidien (NYSE:COV) Frequently Asked Questions

What is Covidien's stock symbol?

Covidien trades on the New York Stock Exchange (NYSE) under the ticker symbol "COV."

How were Covidien's earnings last quarter?

Covidien Ltd (NYSE:COV) released its quarterly earnings results on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.02 by $0.13. The healthcare company had revenue of $2.73 billion for the quarter, compared to the consensus estimate of $2.69 billion. Covidien had a return on equity of 20.06% and a net margin of 19.02%. The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $0.91 earnings per share. View Covidien's Earnings History.

Who are Covidien's key executives?

Covidien's management team includes the folowing people:
  • Gary L. Ellis, President, Chief Executive Officer (Age 61)
  • Charles J. Dockendorff, Chief Financial Officer, Executive Vice President (Age 63)
  • Bryan C. Hanson, Group President, Covidien (Age 50)
  • John H. Masterson, Senior Vice President, General Counsel (Age 54)
  • Michael P. Dunford, Senior Vice President - Human Resources (Age 54)
  • James C. Clemmer, Senior Vice President and President - Medical Supplies Business (Age 53)
  • Amy A. McBride-Wendell, Senior Vice President - Strategy and Business Development (Age 53)
  • Jacqueline F. Strayer, Senior Vice President-Corporate Communications (Age 58)
  • Michael E. Tarnoff, Senior Vice President,Chief Medical Officer (Age 46)
  • Peter L. Wehrly, Senior Vice President, Group President - Developed Markets (Age 57)

Has Covidien been receiving favorable news coverage?

Headlines about COV stock have trended positive recently, Accern reports. Accern scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Covidien earned a news and rumor sentiment score of 0.28 on Accern's scale. They also gave media coverage about the healthcare company an impact score of 46.70 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for Covidien.

How do I buy shares of Covidien?

Shares of COV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Covidien's stock price today?

One share of COV stock can currently be purchased for approximately $0.0350.

How big of a company is Covidien?

Covidien has a market capitalization of $48.98 billion.

How can I contact Covidien?

Covidien's mailing address is 20 On Hatch Lower Hatch Street, Dublin 2, DUBLIN,, Ireland. The healthcare company can be reached via phone at +353-1-4381700.


MarketBeat Community Rating for Covidien (NYSE COV)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  339 (Vote Outperform)
Underperform Votes:  190 (Vote Underperform)
Total Votes:  529
MarketBeat's community ratings are surveys of what our community members think about Covidien and other stocks. Vote "Outperform" if you believe COV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/22/2018 by MarketBeat.com Staff

Featured Article: Tariff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel